Sensorion Names SENS-601 Lead Gene Therapy Program, Files Clinical Trial Applications for GJB2-Related Hearing Loss
Sensorion is focusing on SENS-601 targeting GJB2 mutations, while discontinuing development of its OTOF-targeting program, SENS-501.
Hearing Headlines
Staff's Top Picks
Holistic Hearing Care: New Technologies and Their Whole Person Benefits
Advanced device features, including those found in new AI-powered hearing aids, can influence overall well-being, not just audibility.
Hearing Health News, Trends, and Products — Delivered
From innovative hearing aid technology to best practices in patient care, we deliver the hearing health insights that help you save time, improve outcomes, and grow your practice.Critical Resources
Modern Hearing Solutions
BIHIMA Reports Strong Q1 2026 Hearing Aid Sales
BIHIMA data for Q1 2026 shows increases in ROI sales and UK private sales compared to Q4 2025, with a notable rise in NHS adoption of rechargeable devices.
Treatment Trends
Researchers Use Organoid-on-a-Chip to Model Inner Ear Development
The system aims to provide insight into sensory hair cell development and potential pathways for regeneration.
Diagnostic Testing Tech
Amplifon Digital Health Tools Win International Design Awards
The company’s OtoKiosk digital audiometer and Amplifon App were recognized by the UX Design Awards and iF Design Awards for user experience and innovation.
Efficient Practice Management
Globo, Enghouse VidyoHealth Partner to Streamline Telehealth Interpreter Access
The integration embeds on-demand language services into virtual care workflows to support patients who are Deaf, hard of hearing, or have limited English proficiency.
